drug · small molecule
patient view →venetoclax
Marketedupdated 2mo agoby $ABBV AbbVie Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for chronic lymphocytic leukemia and neoplasm and 38 investigational indications.
targets
Apoptosis regulator Bcl-2
all catalysts(22)
approval · 20
phase 1 2 completion · 1
phase 3 initiation · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that